Director
Gilead Sciences
Dr. Priyanka Madia is currently a Director of Clinical Pharmacology at Gilead Sciences, accountable for clinical pharmacology strategy on early and late-phase clinical studies across multiple therapeutic areas and investigational agents. Dr. Madia obtained her Pharmacy degree from Nirma University (India) and a Ph.D. in quantitative pharmacology and neuroscience from St. John's University, NY. She further pursued a post-doctoral fellowship at SUNY Downstate Medical Center, NY, and training in modeling and simulation at SUNY Buffalo. Dr. Madia has 15 years of post-doctoral experience in research and development and has numerous publications and conference presentations to her credit.
Optimizing Dose Selection for Bispecifics: Lessons Learned
Friday, May 30, 2025
11:00 AM - 12:00 PM East Coast USA Time